Skip to content
Adam Torkildson – Lifestyle
Author:
4D Molecular Therapeutics, Inc.
4DMT Announces New Employment Inducement Grants
July 17, 2026
4DMT Announces Presentation at 44th Annual Scientific Meeting of the American Society of Retina Specialists
June 30, 2026
4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD
June 29, 2026
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital
June 29, 2026
4DMT Announces New Employment Inducement Grants
June 12, 2026
4DMT to Participate in Upcoming Investor Conferences
May 27, 2026
←
Previous Page
1
2